Health and Medicine

March 2, 2012

‘Detangler’ binds, bends and cuts DNA

New details on the DNA-cutting activity of topoisomerase II, a target of anti-cancer drugs, could lead to better chemotherapeutic agents.

By Leigh MacMillan
February 21, 2012

‘Acid test’ for cervical cancer

An inexpensive, low-tech test for cervical cancer may be a good option for screening for the disease among HIV-infected women in developing countries.

By VUMC News and Communications
February 20, 2012

How Cool Cap saved this baby’s life

By VUMC News and Communications
February 20, 2012

Stem cells take heart

Signaling pathway discoveries suggest ways to induce stem cells to become cardiac muscle cells, which could be useful for regenerating damaged heart muscle.

By Leigh MacMillan
Brain image
February 16, 2012

Memory intact in early psychosis

Brain deficits are not present in the early stages of schizophrenia, suggesting it may be possible to delay or prevent the development of brain abnormalities.

By Leigh MacMillan
February 15, 2012

On the tail of RSV infection mechanism

New details about the life cycle of respiratory syncytial virus (RSV) could aid the development of therapies to combat this leading cause of serious illness in infants and the elderly.

By VUMC News and Communications
February 10, 2012

Opinion: Scientific research is essential to state’s economic health

In this Tennessean opinion piece, Vice Chancellor for Health Affairs Jeff Balser discusses the impact scientific research has in Tennessee and the critical importance of continued federal investment in this research.
By VUMC News and Communications
February 8, 2012

Matchmaker for clinical studies

ResearchMatch.org is a web-based registry that is connecting participants and researchers for clinical studies.
By Leigh MacMillan
February 8, 2012

Tool finds connections in genome data

A new analytical tool points to genes that act together to increase disease risk.
By Leigh MacMillan
February 1, 2012

Treatment window for genetic disorder

Treatment with a drug used to prevent organ rejection partially reverses the course of tuberous sclerosis, research in mice suggests.
By VUMC News and Communications
February 1, 2012

Drugs reverse lung cancer cell changes

Drugs that target “epigenetic” changes may help treat or slow the progression of lung cancer.
By VUMC News and Communications
January 26, 2012

Investigators seek clues to resistance to melanoma drug

Investigators at Vanderbilt-Ingram Cancer Center and several other centers may be one step closer to finding out why some melanoma patients relapse after treatment with a promising new drug.
By VUMC News and Communications
January 25, 2012

Protein repairs esophageal DNA damage

A protein involved in repairing DNA damage associated with gastric reflux may play a tumor suppressor role in the esophagus and could represent a target for therapies to combat esophageal cancer.
By VUMC News and Communications
1 … 168 169 170 171 172 … 192